Euan Ashley

Euan Ashley, a leading expert in genomics and cardiovascular medicine at Stanford, dives deep into the transformative power of exercise. He discusses groundbreaking research revealing how exercise fosters vital cellular changes and its surprising benefits for mental health. Ashley also explores gender differences in exercise response and the potential for developing 'exercise pills' that simulate its effects. With insights into the evolutionary role of physical activity, he advocates for a holistic approach to health that emphasizes the necessity of regular movement.

Professor Euan Ashley discusses the groundbreaking work in human genomics and the physiologic effects of exercise from the MoTrPAC initiative. Topics include rapid whole genome sequencing, the science of exercise, targeted drug development, biologic aging, long COVID fatigue, personalized exercise routines, customized training for athletes, and the impacts of extreme exercise on heart health.

Dr. Euan Ashley, a pioneer in genomic sequencing, discusses the use of precision medicine to predict, prevent, and diagnose diseases. Topics include his work with genome sequencing, advances in technology making sequencing cost-effective, the transformation of healthcare with pathogenic labels, the Undiagnosed Disease Network, and the benefits of exercise. Euan is a professor of medicine and genetics at Stanford University and author of The Genome Odyssey.

Euan Ashley, Chair of the Department of Medicine at Stanford and co-founder of biotech firms, shares insights from his groundbreaking work in ultra-rapid genome sequencing. He highlights a pivotal case of diagnosing a newborn's cardiac condition in just eight hours. Euan discusses the integration of AI and wearables in preventive medicine, as well as the genetics behind elite athletic performance. Additionally, he explores the ethical considerations of widespread genetic testing and the potential of generative AI in developing novel therapies.

Euan Ashley, Chair of Medicine at Stanford University, is a trailblazer in precision medicine and genetic sequencing. He shares his inspiring journey from a small Scottish town to the forefront of cardiology, revealing the emotional depth of working in a cardiac intensive care unit. The conversation delves into the power of precision medicine in diagnosing rare diseases, the founding of the Undiagnosed Diseases Network, and the hopeful future of AI in healthcare ethics, underscoring the transformative potential of personalized treatment.